Log In
BCIQ
Print this Print this
 

OQR100, SG200, TYG100

  Manage Alerts
Collapse Summary General Information
Company S-Target Therapeutics GmbH
DescriptionActive S-TIR immunotherapy against gastrin
Molecular Target Gastrin (GAST)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsVaccinate against pancreatic cancer
Regulatory Designation
PartnerOncoQR ML;
Tyg Oncology Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/01/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today